Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) EBITDA Margin (2016 - 2025)

Phibro Animal Health has reported EBITDA Margin over the past 14 years, most recently at 13.46% for Q4 2025.

  • Quarterly results put EBITDA Margin at 13.46% for Q4 2025, up 1574.0% from a year ago — trailing twelve months through Dec 2025 was 10.11% (up 669.0% YoY), and the annual figure for FY2025 was 8.52%, up 328.0%.
  • EBITDA Margin for Q4 2025 was 13.46% at Phibro Animal Health, up from 8.39% in the prior quarter.
  • Over the last five years, EBITDA Margin for PAHC hit a ceiling of 13.46% in Q4 2025 and a floor of 2.28% in Q4 2024.
  • Median EBITDA Margin over the past 5 years was 7.56% (2023), compared with a mean of 5.85%.
  • Biggest five-year swings in EBITDA Margin: tumbled -756bps in 2021 and later surged 1574bps in 2025.
  • Phibro Animal Health's EBITDA Margin stood at 4.66% in 2021, then dropped by -8bps to 4.28% in 2022, then tumbled by -76bps to 1.01% in 2023, then tumbled by -326bps to 2.28% in 2024, then surged by 691bps to 13.46% in 2025.
  • The last three reported values for EBITDA Margin were 13.46% (Q4 2025), 8.39% (Q3 2025), and 8.9% (Q2 2025) per Business Quant data.